dansylsarcosine has been researched along with sulfisoxazole in 1 studies
| Studies (dansylsarcosine) | Trials (dansylsarcosine) | Recent Studies (post-2010) (dansylsarcosine) | Studies (sulfisoxazole) | Trials (sulfisoxazole) | Recent Studies (post-2010) (sulfisoxazole) |
|---|---|---|---|---|---|
| 40 | 1 | 5 | 1,000 | 81 | 58 |
| Protein | Taxonomy | dansylsarcosine (IC50) | sulfisoxazole (IC50) |
|---|---|---|---|
| Endothelin-1 receptor | Homo sapiens (human) | 0.78 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 4.89 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brater, DC; Kirchner, KA; Voelker, JR | 1 |
1 other study(ies) available for dansylsarcosine and sulfisoxazole
| Article | Year |
|---|---|
Binding inhibitors restore furosemide potency in tubule fluid containing albumin.
Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Body Fluids; Dansyl Compounds; Drug Tolerance; Furosemide; Kidney Tubules, Distal; Male; Nephrotic Syndrome; Perfusion; Protein Binding; Rats; Rats, Inbred Strains; Sarcosine; Sulfisoxazole; Warfarin | 1991 |